Details for Patent: 10,105,323
✉ Email this page to a colleague
Which drugs does patent 10,105,323 protect, and when does it expire?
Patent 10,105,323 protects OFEV and is included in one NDA.
Protection for OFEV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in thirty-four countries.
Summary for Patent: 10,105,323
| Title: | Pharmaceutical dosage form for immediate release of an indolinone derivative |
| Abstract: | The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-a- nilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulph- onate. |
| Inventor(s): | Messerschmid; Roman (Biberach an der Riss, DE), Lach; Peter (Ulm, DE), Sokoliess; Torsten (Neu-Ulm, DE), Stopfer; Peter (Warthausen, DE), Trommeshauser; Dirk (Warthausen, DE) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 15/590,487 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,105,323 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,105,323
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | OFEV | nintedanib esylate | CAPSULE;ORAL | 205832-001 | Oct 15, 2014 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Boehringer Ingelheim | OFEV | nintedanib esylate | CAPSULE;ORAL | 205832-002 | Oct 15, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,105,323
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 08157750 | Jun 6, 2008 | |
International Family Members for US Patent 10,105,323
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072060 | ⤷ Sign Up | |||
| Australia | 2009254556 | ⤷ Sign Up | |||
| Brazil | PI0913235 | ⤷ Sign Up | |||
| Canada | 2726648 | ⤷ Sign Up | |||
| Chile | 2010001362 | ⤷ Sign Up | |||
| China | 102056599 | ⤷ Sign Up | |||
| Colombia | 6280468 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
